Skip to content
Storytelling Co – Lifestyle
Author:
Cardurion Pharmaceuticals
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
August 27, 2026